1 month ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee Zacks
Zimmer Biomet receives FDA nod for the Oxford Cementless Partial Knee. It is a PMA Supplement approval. The company plans a nationwide launch in the first quarter of 2025.
Oxford · Premarket · Safety · Zimmer Biomet (ZBH)
X